Evaluation of Convalescent Plasma Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
Elena Diago-Sempere, José Luis Bueno, Aránzazu Sancho-López, Elena Múñez Rubio, Ferrán Torres, Rosa Malo de Molina, Ana Fernández-Cruz (AFC), Isabel Salcedo de Diego, Ana Velasco-Iglesias, Concepción Payares-Herrera, Inmaculada Casas Flecha, Cristina Avendaño-Solà, Rafael Duarte Palomino, Antonio Ramos-Martínez, Belén Ruiz-Antorán
doi: https://doi.org/10.1101/2020.07.31.20165720
Elena Diago-Sempere
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MDJosé Luis Bueno
2Hemotherapy & Apheresis Units. Hematology and Hemotherapy Department. Hospital Universitario Puerta de Hierro Majadahonda
MDAránzazu Sancho-López
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDElena Múñez Rubio
4Internal Medicine Department. Infectious diseases unit. Hospital Universitario Puerta de Hierro Majadahonda
MD, PhDFerrán Torres
5Clinical Pharmacology Department. Hospital Clínic Barcelona. Medical Statistics core facility - IDIBAPS
MD, PhDRosa Malo de Molina
6Servicio de Pneumology. Hospital Universitario Puerta de Hierro Majadahonda
MDAna Fernández-Cruz (AFC)
4Internal Medicine Department. Infectious diseases unit. Hospital Universitario Puerta de Hierro Majadahonda
MD, PhDIsabel Salcedo de Diego
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
RN, PhDAna Velasco-Iglesias
9IIS Puerta de Hierro - Segovia de Arana
MSc, PhD. SCReNConcepción Payares-Herrera
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDInmaculada Casas Flecha
11Flu and Respiratory Virus Unit. Centro Nacional de Microbiología, Instituto de Salud Carlos III
PharmD, PhDCristina Avendaño-Solà
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDRafael Duarte Palomino
13Hematology and Hemotherapy Department. Hospital Universitario Puerta de Hierro Majadahonda
MD, PhDAntonio Ramos-Martínez
4Internal Medicine Department. Infectious diseases unit. Hospital Universitario Puerta de Hierro Majadahonda
MD, PhDBelén Ruiz-Antorán
1Clinical Pharmacology Department. Hospital Univ. Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Madrid, Spain
MD, PhDData Availability
The datasets generated and/or analyzed during the current study will be made available. The corresponding authors will evaluate any request for data sharing and will consult with the steering committee after the publication of the main results.
Posted August 04, 2020.
Evaluation of Convalescent Plasma Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
Elena Diago-Sempere, José Luis Bueno, Aránzazu Sancho-López, Elena Múñez Rubio, Ferrán Torres, Rosa Malo de Molina, Ana Fernández-Cruz (AFC), Isabel Salcedo de Diego, Ana Velasco-Iglesias, Concepción Payares-Herrera, Inmaculada Casas Flecha, Cristina Avendaño-Solà, Rafael Duarte Palomino, Antonio Ramos-Martínez, Belén Ruiz-Antorán
medRxiv 2020.07.31.20165720; doi: https://doi.org/10.1101/2020.07.31.20165720
Evaluation of Convalescent Plasma Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
Elena Diago-Sempere, José Luis Bueno, Aránzazu Sancho-López, Elena Múñez Rubio, Ferrán Torres, Rosa Malo de Molina, Ana Fernández-Cruz (AFC), Isabel Salcedo de Diego, Ana Velasco-Iglesias, Concepción Payares-Herrera, Inmaculada Casas Flecha, Cristina Avendaño-Solà, Rafael Duarte Palomino, Antonio Ramos-Martínez, Belén Ruiz-Antorán
medRxiv 2020.07.31.20165720; doi: https://doi.org/10.1101/2020.07.31.20165720
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4131)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6720)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)